Treatment patterns in patients using triptan and prophylactic medication: an analysis of clinical practice prior to the introduction of CGRP antagonists

PURPOSE: The newly developed calcitonin gene-related peptide (CGRP) antagonists were recently launched on the US and European market, with Switzerland as the second country worldwide. To enable forthcoming comparisons with established migraine therapy, the aim of this study was to provide a comprehe...

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, Carola A, Agosti, Reto, Näpflin, Markus, Blozik, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657656/
https://www.ncbi.nlm.nih.gov/pubmed/31413619
http://dx.doi.org/10.2147/JPR.S207606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657656/
https://www.ncbi.nlm.nih.gov/pubmed/31413619
http://dx.doi.org/10.2147/JPR.S207606

Ejemplares similares